Can GLP-1 Weight Loss Medications Affect Fertility? 

GLP-1 medications like Wegovy and Zepbound are reshaping conversations in healthcare, and the fertility world is paying close attention. At NewLIFE Fertility, our team of reproductive specialists stays current with emerging medicine and science, because your questions deserve real, evidence-based answers. 

One of the most common questions arriving in our clinic right now: can GLP-1 weight loss medications affect fertility? The short answer is yes, and the full story may provide an explanation you didn’t expect. 

Weight Loss and Fertility: How GLP-1 Medications Affect Fertility  

GLP-1 agonists work by mimicking a natural hormone that regulates blood sugar, slows stomach emptying, and signals fullness. Originally developed for diabetes management, newer formulations like tirzepatide (Zepbound/Mounjaro) now achieve average weight reductions of 15 to 20 percent or higher. For reproductive health, that level of weight loss can be truly meaningful. 

According to the American Society for Reproductive Medicine (ASRM), approximately one-third of reproductive-aged individuals have obesity, which can disrupt:* 

• Ovulation 

• Menstrual regularity 

• Hormonal balance 

Obesity can increase the complexity of fertility care, including requiring higher medication doses and presenting challenges during transvaginal ultrasound procedures. Weight loss can help address some of these factors before considering fertility treatment. 

Can GLP-1s Make You More Fertile? 

To be clear, GLP-1 medications are a weight loss tool. Improved fertility is a downstream effect of the metabolic and hormonal changes that follow. By addressing metabolic health through science and medicine, GLP-1 medications may indirectly support conditions more favorable to conception. 

A weight reduction of even 5 to 10 percent can restore regular ovulation in some people, which is the real mechanism behind the widely discussed “Ozempic babies.” When regular ovulation resumes, the opportunity for natural conception can return. 

As this field grows, fertility specialists are increasingly factoring these medications into long-term reproductive planning conversations. 

How GLP-1s Can Treat PCOS 

For individuals living with polycystic ovary syndrome (PCOS), GLP-1 medications have shown particular promise. PCOS is often associated with: 

• Insulin resistance 

• Irregular cycles 

• Elevated testosterone 

Beyond ovulation, GLP-1s can reduce insulin resistance, lower elevated androgen levels, and bring real relief from PCOS symptoms like acne and excess hair growth. That is a meaningful quality-of-life shift, and a medically significant one. 

GLP-1 Medications and IVF: Should You Wait or Move Forward? 

For those already exploring fertility treatment, the relationship between GLP-1 medications and in vitro fertilization (IVF) is a strategic conversation worth having.  

While obesity can play a role in fertility, maternal age remains the strongest predictor of IVF success in reproductive medicine and science. If conception is your primary goal, moving directly into IVF rather than prioritizing weight loss first may be the right call.  

Many reproductive specialists recommend discontinuing GLP-1 medications prior to conception, but the healthy habits built during treatment carry real weight going forward. Aerobic exercise and adequate protein intake are two great priorities to set when looking to conceive.